• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Talking to Parents About Prescribing Stimulants

Talking to Parents About Prescribing Stimulants

May 26, 2019

Because they work better than anything else to help kids focus, stimulant medications are standard treatments for ADHD. But when you suggest prescribing these medications, typically parents have questions and concerns, says Caroline Fisher, PhD, MD, Chief of Child Psychiatry at Samaritan Health Systems in Corvallis, OR.

In an article she wrote for The Carlat Child Psychiatry Report, Dr. Fisher looks at some of the frequently asked questions she gets from parents on stimulants, and gives some suggested answers you can use:

“Don’t stimulants cause growth stunting?” The research is mixed as to whether kids on stimulants have any permanent decrease in height (Vitiello B, Child Adolesc Psychiatr Clin N Am 2008;17(2):459–474). But tell parents that “as long as children on stimulants can maintain their body weight by eating enough, they grow normally.” Most parents will then respond, “Okay, I can feed them—I know how to do that.”

“I’ve heard that stimulants cause heart problems.” In almost all cases of cardiac complications, the problem has been when children have increased their doses quickly from very low to very high. Tell parents that there are very few cases of children who have developed cardiac problems on properly monitored doses. Reassure them that, in a large Florida study of 55,000 children conducted over 10 years, none of the children on stimulants died from a heart attack (Winterstein AG et al., Pediatrics 2007;120(6):e1494–1501). That being said, ask if patients have had a history of cardiac problems before starting stimulants, and if so, order an EKG.

“Won’t they cause my kid to be a zombie?” Some kids become sedated and zombie-like on ADHD medications. Although this is not uncommon, it is dose and situation related. Tell parents that the nice thing about a stimulant is that you can lower the dose (e.g., during less busy activities), or stop it, and no harm has been done.

“Aren’t stimulants addictive?” Tell parents "stimulants are just not as interesting to use as street drugs." Extended release formulations make it so you just can’t get high quickly, and high doses just don’t feel good to most kids. There is a withdrawal syndrome in which kids can get grouchy or headachy, but this is the same kind of withdrawal people have when they stop using caffeine. Kids with ADHD who take stimulants make better decisions and are actually less likely to abuse street drugs.

Subscribers can read the full article in The Carlat Child Psychiatry Report.
General Psychiatry
    Carlat Total Access Subscriptions: Get access to every article on the website.

    Complete access to every article you search on the website.

    Shop for Total Access
    Free Psychiatry Updates
    The latest unbiased psychiatric information sent to your inbox.
    Specify Your Interests
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2639254965.jpg
      General Psychiatry

      Psychopharm Secrets: Starting Meds

      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.